WS #6693

Asian markets rallied on hopes of a US-Iran deal reopening the Strait of Hormuz, with Japan's Nikkei surging 5% to record highs as tech stocks caught up to the global AI rally. SoftBank soared 16.5%, Advantest +7.8%, Tokyo Electron +9.2%. Hong Kong's Hang Seng crossed 26,500 (+1.2%) led by Alibaba and Baidu, while oil producers fell. However, the Philippine Q1 GDP miss (2.8% vs 3.5% expected) highlights the economic damage from the Iran conflict, and a 'plastic shock' is hitting Asia as petrochemical supplies are strangled. The EU provisionally agreed to delay AI rules, a positive for tech regulation sentiment. Samsung halted all home appliance sales in China, pivoting to AI/semiconductors. Cathie Wood sold $8M more AMD at all-time highs and bought Tempus AI. Alphabet's Q1 earnings triggered a $420B market cap surge on 63% cloud revenue growth, re-rating the stock as an AI enterprise. The Iran narrative is STABLE with peace hopes countered by Iranian denial, keeping oil above $100. In the latest window, the dominant theme is the ongoing US-Iran peace talks and their impact on oil and Asian equities. Multiple sources (Bloomberg, FT, EuropeSays) report that hopes for reopening the Strait of Hormuz are pushing Asian shares higher, while oil prices hold above $100. A key development is the report that Iran is reviewing a Washington-backed peace proposal, and Trump says conflict will end if both sides strike agreement. However, a counter-signal emerges: officials say Saudi Arabia—not Iran talks—is the real reason Project Freedom was paused, suggesting the peace narrative may be overblown. Additionally, Iran denied involvement in an attack on a South Korean vessel, adding uncertainty. The AI theme continues with Anthropic's reported $200B, 5-year Google Cloud/TPU commitment, which is a major backlog monetization signal for GOOGL. Elon Musk called Nvidia's GB300 'the best AI computer' as Anthropic partnered with SpaceX to expand Claude AI using 220,000 Nvidia GPUs, bullish for NVDA. PTC surged 7% after beating Q2 estimates. Cytokinetics announced a $700M stock offering, dilutive for CYTK. The narrative arc for Iran is STABLE but with a new counter-signal regarding Saudi Arabia, and the AI narrative is ESCALATING with concrete commitments.